A Phase 111 Randomized controlled clinical trial to compare the efficacy and safety of intra-lesional sodium stibogluconate with intra-lesional meglumine antimoniate treatment in patients with cutaneous leishmaniasis in Sri Lanka.

Category Primary study
Registry of TrialsSri Lanka Clinical Trials Registry
Year 2025
This article has no abstract
Epistemonikos ID: 2cf455a7163ce4b2f958b1f758676a086820a583
First added on: Apr 22, 2026